Workshop - Emerging applications of whole exome sequencing in clinical research
Whole exome sequencing has revolutionized the study of developmental diseases enabling clinical researchers with greater sequencing depth of the target region to identify the genetic variants for their diagnosis.

In this workshop hosted by Ward Medic, it is with pleasure to welcome 3 speakers; Dr Ni-Chung LEE, a clinician at the Department of Medical Genetics, National Taiwan University Hospital, Agilent Technologies Singapore and Ward Medic Part., to share their experiences using whole exome sequencing approach to address their clinical research questions.

Get to learn:
  • Trends in clinical research and case study presentations employing NGS applications to the clinic.
  • Key features and performance of SureSelect Exome V8, V8+UTR, V8+NCV. Sample-to-report WES workflow.
  • Approaches to whole exome sequencing solutions.
New to Whole Exome Sequencing?
Register to the event and receive a promotion code to enjoy discount off your next whole exome sequencing project.

Register to the event now
Hosted by:
Novogene's distributor in Thailand
Register to attend one of the following session.
22nd August 2022 Chulalongkorn University
2pm to 4.30pm

23rd August 2022
Siriraj Hospital, Mahidol University
9am to 11:30am
















(Tick the area of research focus that applies.)
Note: You'll receive a confirmation email from us that includes a Zoom link and a promotional code after the registration.

Please email supamard@wardmedic.com, If you have questions about registration.
Meet the Speakers
Dr. Ni-Chung LEE
Department of Medical Genetics, National Taiwan University Hospital

Advances in Genetic Diagnosis - Postnatal Perspective
Dr. Chee Yang LEE
Senior Field Application Scientist
Diagnostics & Genomics Group, South Asia Pacific
Agilent Technologies Singapore (Sales) Pte Ltd

SureSelect Human All Exon V8 - Toward an Integrated Exome Sequencing Solution
Supamard Chooyim
Product Manager
Ward Medic Ltd., Part

Making Genomic Service Accessible and Affordable
NovogeneAIT Genomics is a joint venture between Novogene and AIT Biotech, focusing primarily on the Asia Pacific, Middle East, and Africa (AMEA) region. We are a leading provider in genomic services and solutions for research and clinical applications, with operations in Singapore, Japan, Australia, India, Hong Kong, China, the United States, the United Kingdom, and the Netherlands.


NovogeneAIT Genomics Pte. Ltd. (Regional Office for Asia Pacific, Middle-East & Africa)
11 Biopolis Way, #10-11 Helios Singapore 138667  
© 2022 Novogene Co., Ltd. All Rights Reserved